Thomas Prebet, MD, PhD

Associate Professor

Departments & Organizations

Internal Medicine: Hematology

Yale Cancer Center: Developmental Therapeutics | Hematology Program

Yale Medicine

Biography

After completing his doctorate in medical hematology and oncology in Lyon, France, Dr. Prebet joined Institut Paoli-Calmettes in Marseille, France and completed a fellowship in Johns Hopkins University (Baltimore, MA, USA) as a Fullbright alumni. Dr. Prebet is currently associate director of the myeloid malignancies program in the hematology department of the Yale Cancer Center, New haven, CT. He is developing myeloid malignancies clinical trials and translational works for advanced phase acute myeloid leukemia and myelodysplastics syndromes. The current works gave the basis for defining demethylating agent failure outcome (Prebet JCO 2011, Hematologica 2012, British Journal of Hematology 2012), contributed to his knowledge of combinations therapies based on HDAC inhibitors (Prebet JCO 2014, Prebet Leuk Res 2014) and gave the first insights on the implication of Wnt non canonical pathway in acute myeloid leukemia (Prebet Blood 2011). Dr Prebet is the coordinating investigator of several clinical trials for myelodysplastic syndromes patients and contributed to 80 peer reviewed manuscript.

Education & Training

PhD Centre de Recherche en Cancerologie (2009)
MS Claude Bernard University (2005)
MD Montpellier University (2000)

Edit this profile

Contact Info

Thomas Prebet, MD, PhD
Patient Care Location
Smilow Cancer Hospital at Yale New Haven
35 Park Street

New Haven, CT 06511
View on map...
Mailing Address
Hematology333 Cedar Street
PO Box 208028

New Haven, CT 06520-8028